- Home
- LGN vs HCM Comparison
LGN vs HCM Comparison
Compare LGN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGN
- HCM
- Stock Information
- Founded
- LGN 1963
- HCM 2000
- Country
- LGN United States
- HCM Hong Kong
- Employees
- LGN N/A
- HCM N/A
- Industry
- LGN
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- LGN
- HCM Health Care
- Exchange
- LGN Nasdaq
- HCM Nasdaq
- Market Cap
- LGN 3.1B
- HCM 2.6B
- IPO Year
- LGN 2025
- HCM N/A
- Fundamental
- Price
- LGN $31.67
- HCM $16.09
- Analyst Decision
- LGN
- HCM Sell
- Analyst Count
- LGN 0
- HCM 1
- Target Price
- LGN N/A
- HCM $13.75
- AVG Volume (30 Days)
- LGN 1.8M
- HCM 55.3K
- Earning Date
- LGN 01-01-0001
- HCM 08-07-2025
- Dividend Yield
- LGN N/A
- HCM N/A
- EPS Growth
- LGN N/A
- HCM N/A
- EPS
- LGN N/A
- HCM 0.53
- Revenue
- LGN $2,213,862,000.00
- HCM $602,197,000.00
- Revenue This Year
- LGN N/A
- HCM N/A
- Revenue Next Year
- LGN N/A
- HCM $15.49
- P/E Ratio
- LGN N/A
- HCM $6.00
- Revenue Growth
- LGN 77.61
- HCM N/A
- 52 Week Low
- LGN $26.96
- HCM $11.51
- 52 Week High
- LGN $34.40
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- LGN N/A
- HCM 48.41
- Support Level
- LGN N/A
- HCM $15.50
- Resistance Level
- LGN N/A
- HCM $16.35
- Average True Range (ATR)
- LGN 0.00
- HCM 0.31
- MACD
- LGN 0.00
- HCM -0.06
- Stochastic Oscillator
- LGN 0.00
- HCM 26.40
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.